Allaway, G. P. (2006). Development of Bevirimat (PA-457): First-in-class HIV maturation inhibitor. BioMed Central.
Style de citation ChicagoAllaway, Graham P. Development of Bevirimat (PA-457): First-in-class HIV Maturation Inhibitor. BioMed Central, 2006.
Style de citation MLAAllaway, Graham P. Development of Bevirimat (PA-457): First-in-class HIV Maturation Inhibitor. BioMed Central, 2006.
Attention : ces citations peuvent ne pas être correctes à 100%.